| | Class 2 Device Recall BioTek Gen5CL Microplate Data Collection and Analysis Software |  |
| Date Initiated by Firm | March 12, 2009 |
| Date Posted | September 18, 2009 |
| Recall Status1 |
Terminated 3 on May 18, 2015 |
| Recall Number | Z-2223-2009 |
| Recall Event ID |
52218 |
| Product Classification |
Colorimeter, photometer, spectrophotometer for clinical use - Product Code JJQ
|
| Product | BioTek Gen5CL Microplate Data Collection and Analysis Software.
Intended for clinical lab use with ELx800 and ELx808 microplate readers, offers preprogrammed clinical diagnostic assays within a PC-based application. |
| Code Information |
Software versions 1.07 and lower. |
| FEI Number |
1217454
|
Recalling Firm/ Manufacturer |
BioTek Instruments, Inc. Highland Park/Box 998 Winooski VT 05404
|
| For Additional Information Contact | Lenore Buehrer 802-655-4040 |
Manufacturer Reason for Recall | Software design allowed false negatives to be read when wells are dark. |
FDA Determined Cause 2 | Software design |
| Action | BioTek Instruments, Inc. issued a "Product Recall Notification" dated March 13, 2009 information customers of the affected product. Follow-up letters with software installation instructions were sent March 25, 2009.
For further information, contact BioTek Instruments, Inc. at 1-888-451-5171 extension 405. |
| Quantity in Commerce | 13 |
| Distribution | Worldwide Distribution -- United States (MN, CA, IL, MA, MI, CA, GA, FL, AZ and TX) and Peru. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|